Bafna Pharmaceuticals Limited (BAFNAPH.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.59B |
| Enterprise Value | 2.94B |
| P/E Ratio | 44.5 |
| PEG Ratio | 0.26 |
| Price/Sales Ratio | 3.28 |
| Price/Book Ratio | 5.14 |
| Enterprise/Revenue | 3.51 |
| Enterprise/EBITDA | 27.16 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.07 |
| Operating Margin | 0.07 |
AD
Management Effectiveness
| Return On Assets | 0.06 |
| Return On Equity | 0.12 |
Income Statement
| Revenue | 1.51B |
| Revenue/Share | 63.55 |
| Gross Profit | 201.42M |
| EBITDA | 207.04M |
| Net Income | 111M |
| Diluted EPS | 4.69 |
Balance Sheet
| Total Cash | 20.25M |
| Total Cash/Share | 0.85 |
| Total Debt | 374.33M |
| Total Debt/Equity | 0.39 |
| Current Ratio | 1.57 |
| Book Value Per Share | 40.57 |
Price History
| 52-Week Change | 144.24 |
| 52-Week High | 227 |
| 52-Week Low | 78.18 |
| Moving Average 50 Days | 162.68 |
| Moving Average 200 Days | 143.77 |
Statistics
| Average Volume | 15,815 |
| Shares Outstanding | 23.66M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | August 26, 2019 |
AD
